France and Germany have a reaction to the EU of the US trade deal

The leaders of the two largest economies in Europe lead a choir of gloomy reactions to the trade deal achieved between EU chief Ursula von der Leyen and US President Donald Trump.

German Chancellor Friedrich Mertz said the agreement would “hurt” his nation’s finances, while French Prime Minister Francois Bayro said he was tantamount to “submission”.

The reaction was reduced through the block – although several capitals acknowledged that signing an uneven deal was worth it to prevent a completely trade war.

He will see a 15% tariff for most EU exports to the United States – half an interest rate at risk of Trump – in exchange for Europe, which buys more American energy and reduces taxes on some imports.

Following the private conversations on the Trump’s Turnberry Golf Course in Scotland, von der Leyen described the agreement as a “huge deal” while Trump said it would bring the US and the EU closer.

The deal will require the approval of all 27 EU members, each of which has different interests and levels of export of goods exports to the United States.

Although no Member State states that she intended to block him to enter into force, there was a small celebration among European leaders.

Mertz warned that US economies and European economies would be negatively influenced, but also said the Brussels Negotiation team “could not expect to achieve more” against an US president, who decided to balance relations with large trading partners.

Bairu was a more project, he wrote to the X: “This is a dark day when the Union of Free Peoples, gathered to confirm its common values and to defend its common interests, to reconcile itself.”

Hungarian Prime Minister Viktor Orban, a close ally of Trump, said the US president is eating von der Leyen for breakfast.

Spanish Prime Minister Pedro Sanchez said he would support him “without any enthusiasm.”

There was some relief in Europe that a deal was concluded.

Finland’s Prime Minister said he would provide “such a necessary predictability” while Irish Trade Minister Simon Harris said he brings security “essential for jobs, growth and investment.”

Defending his conditions at a press conference on Monday, EU Commissioner Maros Sefkovic said it was “the best deal we can get in very difficult circumstances.”

He also pointed out the effects of the security of maintaining cardiac commercial relations with the United States in the context of Ukraine.

In ensuring that Europe and the United States are “aligned with geopolitical issues today,” he said, came with an “extra price”.

During the weeks that make up the final conversations in the EU, there was a growing appetite among some European leaders to increase the pressure on Trump, using the so-called measures to combat the odds that would block US companies’ access to the European markets.

But with 30% tariffs that are coming, the EU concluded a deal on behalf of its members – one that would still strike an economic blow, but less heavy, which was afraid when Trump initially threatened taxes on imports.

Von der Leyen tried to present him as a success on Sunday – but by Monday, even his European People’s Party leader Manfred Weber described him as “damage control”.

Although the broad outlines of the transaction have been agreed, its details will be finalized after technical conversations.

The initial business reaction in the Atlantic was similar to enthusiasm. The National Foreign Trade Council based in Washington said any deal that avoids trade war is “Welcome Progress”.

However, he warned that any “short -term profits” of a 15% tariff could ultimately leave the United States “isolated from a major ally and Erode Trust in the long run.”

The previous fare without tariffs, according to him, allowed industries, including aerospace space and pharmaceuticals, to flourish “on both sides.”

The initial framework for deals “leaves a number of anxious EU policies available,” she said, including what she calls a “discriminatory digital program” and “unfair policies to restore pharmaceuticals.”